{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-001389","form_type":"8-K","ticker":"IMDX","cik":"0001642380","company_name":"Insight Molecular Diagnostics Inc.","filed_at":"2025-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.280969+00:00","generated_at":"2026-05-28T06:47:40.688098+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Oncocyte amends lease; terminates extension right, sets expiry Oct 2027, schedules $1.7M LC reduction","bullets":["Amendment entered Jan 2, 2025 with Induce Biologics and landlord Cushing Ventures.","Original lease expires Oct 31, 2027; all extension rights cancelled.","Letter of credit reduced by $60,714.29/month starting July 1, 2025 from $1.7M.","Reduction contingent on no continuing default; no assurance of reduction.","Reductions correspond to restricted cash on balance sheet."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-001389","json":"https://secwatch.observer/filing/0001493152-25-001389.json","markdown":"https://secwatch.observer/filing/0001493152-25-001389.md","text":"https://secwatch.observer/filing/0001493152-25-001389.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642380/000149315225001389/0001493152-25-001389-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642380/000149315225001389/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T06:47:40.688098+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}